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Abstract
Background: Adult mice have a remarkable capacity to regenerate functional alveoli following
either lung resection or injury that exceeds the regenerative capacity observed in larger adult
mammals. The molecular basis for this unique capability in mice is largely unknown. We examined
the transcriptomic responses to single lung pneumonectomy in adult mice in order to elucidate
prospective molecular signaling mechanisms used in this species during lung regeneration.
Methods: Unilateral left pneumonectomy or sham thoracotomy was performed under general
anesthesia (n = 8 mice per group for each of the four time points). Total RNA was isolated from
the remaining lung tissue at four time points post-surgery (6 hours, 1 day, 3 days, 7 days) and
analyzed using microarray technology.
Results: The observed transcriptomic patterns revealed mesenchymal cell signaling, including up-
regulation of genes previously associated with activated fibroblasts (Tnfrsf12a, Tnc, Eln, Col3A1),
as well as modulation of Igf1-mediated signaling. The data set also revealed early down-regulation
of pro-inflammatory cytokine transcripts and up-regulation of genes involved in T cell development/
function, but few similarities to transcriptomic patterns observed during embryonic or post-natal
lung development. Immunohistochemical analysis suggests that early fibroblast but not
myofibroblast proliferation is important during lung regeneration and may explain the
preponderance of mesenchymal-associated genes that are over-expressed in this model. This again
appears to differ from embryonic alveologenesis.
Conclusion: These data suggest that modulation of mesenchymal cell transcriptome patterns and
proliferation of S100A4 positive mesenchymal cells, as well as modulation of pro-inflammatory
transcriptome patterns, are important during post-pneumonectomy lung regeneration in adult mice.
Background
Pulmonary emphysema is an example of a chronic disease
with parenchymal destruction, where repair is relatively
ineffectual [1]. To provide effective therapies for treating
this disease, a better understanding of the cellular and
molecular processes that govern the phenomenon of lung
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regeneration, and in particular alveolar regeneration, is
crucial. An important approach is the analysis of tissues
from animal species that retain a high degree of regenera-
tive capacity. Adult mice are capable of regenerating func-
tional alveoli following either lung resection or injury to a
greater degree than the regenerative capacities observed in
larger adult mammals [2,3]. In healthy adult mice (or
rats) unilateral pneumonectomy evokes compensatory
lung regeneration from the remaining lung lobes [4], in
part through neoalveolarization within the existing paren-
chyma [5]. This regenerative process is characterized by
restoration of lung volume, surface area, morphometry,
DNA and protein content within 14 days, as demon-
strated by our lab as well as others [6,7]. Despite a pleth-
ora of macrophysiologic and morphometric studies on
lung regeneration in rodents and larger animals [2], the
cellular and molecular mechanisms that regulate this
process are not well understood. Previous studies using
gene expression have focused on specific pathways [8]
rather than global transcriptomic approaches. For exam-
ple, using a gene array (588 genes) designed for analysis
of transcription factors, Landenberg et al demonstrated a
2-fold or greater up-regulation of six genes, including
early-growth response gene-1 (Egr-1), Nurr77, tristetrap-
rolin, the inhibitor of kB-alpha (IkB-alpha), Klf-4 (GKLF)
and LRG-21, all within two hours of pneumonectomy in
mice [9]. The authors concluded that expression of early
transcription factors (i.e. early immediate genes) activated
by mechanical stress trigger a cascade of growth signals
that promote lung regeneration. Likewise, repeated over-
inflation of the murine lung soon after pneumonectomy
(30 min) was associated with over-expression of the
proto-oncogenes  c-fos  and  junB  [10], underscoring the
ability of pneumonectomy-induced mechanical stretch to
evoke transcription factors. Indeed, lung stretch by
mechanical ventilation without pneumonectomy induces
similar early immediate gene transcription [11].
While past studies have revealed early immediate genes
that participate in the activation of lung regeneration, the
majority of the regenerative process takes place over a pro-
longed period (7-14 days). Gene expression patterns cor-
responding to important biologic processes such as
cellular proliferation, matrix formation, angiogenesis, and
progenitor cell differentiation have not been fully charac-
terized. It is also unclear from past studies why processes
such as matrix formation and angiogenesis occur during
the remodeling process, but are not associated with fibro-
sis in this context.
The objective of this study was to measure the effects of
pneumonectomy (vs. sham surgery) on gene transcrip-
tome patterns that are robustly expressed (fold change
≥1.5, or ≤ -1.5) at multiple time points during lung regen-
eration. Therefore, we analyzed the transcriptome (over
39,000 genes) from mouse lung tissues following unilat-
eral pneumonectomy using Affymetrix GeneChip micro-
array technology. Samples were taken at four time points
(6 hours, 1 day, 3 days and 7 days) post-pneumonectomy
spanning the period during which the bulk (>80%) of
lung regeneration occurs, as measured by changes in vital
capacity [12]. Following analysis of the transcriptomic
patterns, an immunohistochemical study of the regenerat-
ing parenchyma using the fibroblast markers S100A4 and
αSMA was also performed at two points during lung
regeneration (3 days and 7 days) to further elucidate the
role of fibroblasts in this process.
Methods
Animals used for microarray analysis and q RT-PCR
Mice used in this study were adult (10-12 week) female
C57BL/6 (20-25 g) obtained from Jackson Laboratories.
All experiments were performed in accordance with NIH
guidelines, as dictated by Institutional Animal Care and
Use Committee at Tufts University. For each of the four
time points, the mice were divided into two groups: (1)
pneumonectomy (PNY) and (2) sham operated (SHAM -
thoracotomy without lung resection), with eight animals
in each group. Mice were anesthetized by intraperitoneal
injection of ketamine (50-75 mg/kg) and xylazine (5 mg/
kg), and then received 2 ml of warmed normal saline and
100 mg/kg sodium ampicillin subcutaneously. Orotra-
cheal intubation was performed under direct visualization
using a 20-gauge catheter (BD Insyte catheter; Becton,
Dickinson and Co, Franklin Lakes NJ) over a flexible
stylet. Mice were secured in supine position, and mechan-
ically ventilated (AUT6110, Buxco Electronics, Wilming-
ton, NC) at 200 tidal breaths of 0.3 ml of room air per
minute, at positive end-expiratory pressure of 3 cm H2O
during surgery and recovery.
Pneumonectomy procedure
After achieving adequate anesthetic depth (absence of
response to toe-pinch) the left thoracic wall was clipped
and disinfected. The skin, chest wall and pleura were
incised at the 5th intercostal space, and the left lung was
gently lifted through a ~5-7 mm incision and ligated at the
hilum with 4-0 silk (Sofsilk, Synture Norwalk Ct). The
lungs were then inflated to 30 cmH20 airway pressure, and
the chest wall closed during this inflation with a single
interrupted suture. The skin was closed with 5-0 PDS in a
simple interrupted pattern. Mice were extubated at the
onset of vigorous spontaneous breathing. The mice recov-
ered from surgery in a warmed cage, and post-operative
pain was managed with buprenorphine subcutaneously
(0.05 mg/kg) as soon as mice showed conscious motor
control, and every 12 hours thereafter as needed (<3
days). Chow, nutrient gel (on the cage floor), and water
were provided ad libitum. Sham pneumonectomy animals
underwent an identical procedure, except that after the
thoracotomy, the chest was left open for 5 minutes to sim-Respiratory Research 2009, 10:92 http://respiratory-research.com/content/10/1/92
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ulate the conditions of the pneumonectomy group with-
out removal of the left lung, then closed as described.
Tissue preparation and RNA isolation
The mice were anesthetized as above at 6 hours, 1 day, 3
days and 7 days after surgery (PNY or SHAM) then eutha-
nized by cervical dislocation. The pulmonary vasculature
was perfused with ice cold Hanks balanced salt solution,
the trachea cannulated, and the lungs removed en bloc.
RNA preservation was achieved by flooding the lung
intratracheally with RNAlater solution (Qiagen #76104),
followed by storage of lung tissue samples in RNAlater at
-80°C.
RNA isolation and microarray analysis
Equal amounts of lung tissue were pooled from eight ani-
mals in each group (PNY or SHAM at each of 4 time
points) to minimize biological variability [13]. Total RNA
was prepared from the dissected lung tissue using the Qia-
gen RNAeasy mini kit (Qiagen #74104) according to the
manufacturer's directions. The total RNA samples from
the primary purification were purified a second time on
Qiagen RNAeasy columns according to the manufac-
turer's instructions. Total RNA concentrations, A260/
A280 and A260/A230 ratios were determined using a
NanoDrop ND1000 spectrophotometer. All microarray
analysis was performed as described in the Affymetrix
GeneChip Expression Analysis Technical Manual using
Affymetrix Mouse Genome 430 2.0 GeneChips and the
One-Cycle cDNA Synthesis and HT IVT Labeling kits
(Affymetrix Inc.). The complete microarray dataset is
available (accession number GSE15999 at: http://
www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE15999).
Microarray data analysis on PNY versus SHAM animals 
(time-independent)
The initial goal in the analysis was to identify genes differ-
entially regulated in the comparison between pneumon-
ectomized and sham-operated animals. By treating all
time points as replicates within their respective groups
two datasets were created (PNY and SHAM), each with an
n = 4. The corresponding Affymetrix CEL files were back-
ground corrected, summarized and quantile-normalized
using the RMA library in BioConductor http://www.bio
conductor.org, yielding one expression value per probe set
for each of the 8 arrays [14]. Based on the 'Rank Products'
algorithm proposed by Brietling, et. al [15], the RankProd
library was employed to find differentially expressed
genes. This algorithm works by performing comprehen-
sive pair-wise comparisons to calculate a rank statistic RPg,
defined as the probability of seeing the observed, pair-
wise expression patterns for any given gene g. As a vehicle
for measuring statistical significance a non-parametric P-
value is also calculated, using 1000 permutations to deter-
mine how often the calculated RPg statistic would occur by
chance alone. Finally, the RankProd library compares
average expression between the two groups to derive a
fold-change value. Genes with a reported P-value < 0.001
and a fold-change ≥ 1.5 or ≤ -1.5 were selected for further
investigation.
Microarray data analysis to identify temporal changes in 
lung regeneration (time dependent)
In a second analysis, the focus was shifted to temporal
changes in gene expression during lung regeneration as
opposed to overall transcriptomic patterns. With only one
array per experimental condition at each time point, deri-
vation of statistical measures and the subsequent search
for truly differentially expressed genes can be challenging.
However, the S-Score algorithm described by Zhang et al.
(2002) and Kerns et al. (2003) provides a method for
determining statistical significance when biological repli-
cates are not available by applying pair-wise comparisons
to probe-level data [16-19]. On average, the Affymetrix 3'
IVT platform contains 22 probes for every transcript repre-
sented on the array. Using this information directly, the S-
Score algorithm has shown good sensitivity when com-
pared to many other existing analysis methods without
sacrificing specificity (including RMA, dChip and MAS5),
and can produce accurate results when no biological rep-
licates are present [18,19]. This is particularly applicable
and appropriate to our individual time point datasets in
which we have only one paired array set for each time
point. Using the S-Score algorithm, the relative change in
probe pair intensity is calculated to convert the probe pair
signal differences into multiple measurements with equal-
ized errors. The relative changes for each probe pair are
then summed to form the S-score, which represents a sin-
gle measure of the significance of change for the gene in
question[19]. By definition, S-score is related to P-value
by an exponential relation, and a value of 3 corresponds
to a P-value of 0.003 [16,19,19]. Genes with an S-score ≥
3.0 or ≤ - 3.0 (P ≤ 0.003) were selected for further analysis.
Ingenuity Pathways Analysis
For selected genes (genes with a P-value < 0.001 and a
fold-change ≥ 1.5 or ≤ -1.5 for the time-independent anal-
ysis; genes with an S-score ≥ 3.0 or ≤ - 3.0 (P ≤ 0.003) for
the time-dependent analysis), Ingenuity Pathway Analysis
(IPA) version 2.0 (Ingenuity® Systems Inc, Redwood City,
CA; http://www.ingenuity.com) was used to search for
biological functions and interrelationships between sig-
nificantly modulated genes in PNY versus SHAM mice.
IPA provides a large manually curated database contain-
ing over 200,000 full text articles and information about
thousands of human, mouse and rat genes [20] with
which experimental data sets can be statistically com-
pared. Genes from the dataset were overlaid onto a global
molecular network developed from information con-
tained within the IPA database, and networks of genes in
the dataset were then algorithmically generated based onRespiratory Research 2009, 10:92 http://respiratory-research.com/content/10/1/92
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their connectivity (both direct and indirect relationships).
Each network displays the type of relationship between
two gene products, including genes that are not signifi-
cantly altered in the user's microarray data set. The net-
works are ranked depending on the number of
significantly expressed genes they contain, based on a P-
value that indicates the likelihood of the genes in a net-
work being found together due to chance. A score of 2
indicates a 1 in 100 chance that the focus genes of interest
were linked in the network by chance rather than a direct
biological relationship. Therefore, scores of 2 or higher
have at least a 99% confidence level of not being gener-
ated by random chance alone [20].
Quantitative reverse transcription PCR validation
Total RNA from individual lung tissue samples (n = 3)
from each group (PNY vs. SHAM) at the 1 day time point
was prepared using TRIzol (Invitrogen, Carlsbad CA) as
recommended by the manufacturers, followed by the Qia-
gen RNAeasy mini kit (Qiagen #74104) according to the
manufacturer's directions. Total RNA concentrations and
RNA quality was determined using an Agilent Bioanalyzer
(Agilent Technologies Inc, Wilmington DE), with RIN > 7
for all samples. The RNA from each of the six individual
samples was then subjected to genomic DNA elimination
and first strand cDNA synthesis using a commercial kit
(RT2 First Strand Kit, SA Biosciences) to generate the cDNA
templates for PCR amplification. Quality control was per-
formed using the SA Biosciences QC qRT-PCR array (SA
Biosciences) to test for any inhibition of cDNA synthesis,
or presence of genomic DNA contamination. Gene
expression assays were performed using sets of premade
mouse primer pairs (SA Biosciences) for Igf1, Cyr61,
Igfbp2, Igfbp3, Tnfrsf12a, Tnc, Col3A1 and Eln (see Table
1). Quantitative PCR was performed using a Stratagene
MX3000P Detection system, and RT2 qPCR SYBR green
PCR Master Mix (SA Biosciences), according to the manu-
facturer's recommended protocol. Each sample was ana-
lyzed in triplicate, and relative gene expression (PNY
versus SHAM) was calculated using the comparative Ct
method [21] after normalization to the housekeeping
gene Gapdh, which did not show differences in expression
between SHAM and PNY mice (see online microarray
dataset - accession number GSE15999 at: http://
www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE15999).
Animals used for immunohistochemical study
Mice used for the immunohistochemistry study were also
adult (10-12 week) female C57BL/6 (20-25 g) obtained
from Jackson Laboratories. For each time point (3 days
and 7 days), the mice were divided into two groups: (1)
pneumonectomy (PNY) and (2) sham operated (SHAM -
thoracotomy without lung resection), with three animals
in each group. Unilateral pneumonectomy or sham thora-
cotomy were performed as described above, and after
recovery, all mice were fed BrdU in drinking water (0.8
mg/ml) between days 0-3 (day 3 time point) or 4-7 (day
7 time point) before euthanasia.
Immunohistochemistry
The mice were anesthetized as above at 3 days and 7 days
after surgery (PNY or SHAM) then euthanized by cervical
dislocation. Following median sternotomy, the pulmo-
nary vasculature was perfused with ice cold Hanks bal-
anced salt solution, the trachea cannulated, and the lungs
removed en bloc. Tissue fixation was achieved with intrat-
racheal 10% buffered formalin at 25 cmH20 overnight.
The trachea was then ligated, and the lung was embedded
in paraffin. Immunofluorescent staining (IF) was per-
formed on 5 μm paraffin sections. Primary antibodies
included the monoclonal mouse antibody anti-BrdU
(Santa Cruz, dilution 1:100), the monoclonal rabbit anti-
body anti-S100A4 (AbCam, dilution 1:100), and the
monoclonal mouse antibody anti-αSMA (Santa Cruz,
dilution 1:100). Tissue sections were deparaffinized and
hydrated using standard methods, and antigen retrieval
was performed using a citrate buffer (pH 6.0) and micro-
wave heating (5 mins at high, 15 mins at 40% power). Tis-
sues were washed (TBS with 0.1% Tween) three times
Table 1: Validation of the microarray data using quantitative rt-PCR
Pathway Gene SABiosciences Catalog # q-rtPCR (d1)* Microarray (TI)*
Igf-1 signaling Igf1 PPM03387E 1.4 (1.0 - 1.9) 1.5
Cyr61 PPM05012A 4.0 (3.0 - 4.9) 1.6
Igfbp2 PPM05178A 1.1 (-1.6 - 2.0) 1.5
Igfbp3 PPM03820E -4.0 (-8.0 - -4.0) -1.6
Fibroblast activation Tnfrs12a PPM27298A 2.8 (1.8 - 4.3) 1.5
Tnc PPM03804E 5.0 (2.6 - 9.8) 2.2
Col3A1 PPM04784B 1.2 (-1.1 - 1.6) 1.5
Eln PPM36834A 1.4 (1.1 - 2.2) 1.6
* The numbers represent the mean fold change for each gene transcript. The numbers in brackets represent the estimated range of fold change of 
gene expression seen in pneumonectomy animals (n = 3) compared to sham animals (n = 3), based on the standard error calculated from the 
pneumonectomy ΔCt values. For the microarray data, all expression values are significant with P < 0.001. TI - time-independent.Respiratory Research 2009, 10:92 http://respiratory-research.com/content/10/1/92
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before a 20 minute protein block (Dako, Carpinteria, CA),
and then exposed to the primary antibodies (15-18 hours
at 4 degrees Celsius). Detection of the primary antibodies
was achieved using donkey anti-mouse Alexa Fluor 594
(red) for BrdU and donkey anti-mouse or donkey anti-
rabbit Alexa Fluor 488 (green) for αSMA and S100A4
respectively, both at 1:200 (30 mins at 37 degrees Cel-
sius). The appropriate isotype control assays were also
performed; non-specific staining was not observed.
To examine the proliferation of S100A4 positive paren-
chymal cells during lung regeneration, 20 randomly
selected high power fields (400×) were photographed dig-
itally for each sample (3 PNY and 3 SHAM animals at each
time point). Cells were counted (averaging 50-100 nucle-
ated cells/HPF) and divided into four categories (nucle-
ated cells (DAPI), S100A4 positive, BrdU positive, and
double positive (S100A4+BrdU), and the mean percent-
age of S100A4 cells/nucleated cells, BrdU cells/nucleated
cells and S100A4+BrdU/nucleated cells were obtained. A
two-way ANOVA and independent t-tests were performed
to test for significance (P < 0.05) between PNY and SHAM,
and between 3 day and 7 day time points.
Results
Microarray analysis and validation
Microarray data was collected from pooled lung samples
(n = 8) at four time points (6 hr, 1 day, 3 day and 7 day)
during post-pneumonectomy lung regeneration from
both PNY and SHAM animals. As mentioned in the meth-
ods section, the data obtained from these microarrays
were analyzed in two different ways. First, data from each
time point was combined in a non-parametric replicate
analysis generating a time-independent data set, PNY vs.
SHAM, with four replicates. In this time-independent
analysis to identify consistently regulated genes, 179
genes were identified as differentially expressed between
PNY and SHAM (P < 0.001) with fold changes of ≥ 1.5 or
≤ -1.5 (Table S1, additional file 1). Second, global gene
expression patterns in the lung were analyzed independ-
ently at each of the four time points following pneumon-
ectomy (6 hours, 1 day, 3 day and 7 day). In this time-
dependent analysis, 346, 472, 556 and 733 genes were
differentially expressed between PNY and SHAM at 6
hour, 1 day, 3 day and 7 day post-pneumonectomy
respectively (complete data not shown), with an S-score
of ≥ 3 or ≤ -3 (equivalent to P < 0.003). In addition, vali-
dation of the microarray data was performed using quan-
titative rt-PCR. PCR was performed using 8 genes that
showed modulated expression across several different
areas of interest at the 1 day time point, as well as in the
time-independent analysis. The expression patterns
observed using qRT-PCR are similar to patterns observed
by microarray (see Table 1).
Time-independent transcriptomic patterns during lung 
regeneration
A complete list of genes with significantly (P < 0.001)
altered expression (fold change ≥ 1.5, or ≤ -1.5) in the
time-independent analysis of post-pneumonectomy lung
regeneration is compiled in Table S1, additional file 1.
This table is organized into biological functions that are
prevalent during lung regeneration including cell cycle/
cell division, DNA synthesis or repair, cell proliferation,
extracellular matrix, cytoskeleton, inflammatory, fibrotic,
and immune responses, and protein phosphorylation,
and miscellaneous biological functions. From this table,
several important transcriptomic patterns emerge. First is
the significant up-regulation of many cell cycle, cell divi-
sion, and DNA synthesis-related genes. Many genes
involved in cell proliferation are also differentially
expressed, including members of Igf1 signaling (up-regu-
lation of Igf1, Igfbp2, Cyr61 and Pappa2 and down-regu-
lation of Igfbp3), as well as Ctgf, Hbegf and Tnfrsf12a.
Components of the extracellular matrix including Tnc,
Eln, Fbn1, Col3A1, Col5a2 and Vcan are up-regulated, as
well as two members of the Adamts metalloproteinase
family (Adamts2, Adamts9). Interestingly, genes relating
to goblet cell hyperplasia and mucous production are also
up-regulated (Clca3, Agr2, Slc26a4), with differential
expression of other genes associated with inflammatory,
fibrotic or immune responses (up-regulation of Reg3g,
Ear11, Retnla, Nappa, and Ccr9; down-regulation of Arg1,
CD5L and Alox15).
Figure 1 illustrates the top networks defined by IPA for the
time-independent analysis of post-pneumonectomy lung
regeneration. These networks represent diverse relation-
ships (represented as a line) between different genes (rep-
resented as filled shapes). Red nodes represent genes that
increased in expression in animals after pneumonectomy
compared to sham-operated animals, whereas green
nodes represent genes that decreased in expression in ani-
mals after pneumonectomy compared to sham-operated
animals. IPA network analysis corroborated the impor-
tance of cell cycle regulation, cell movement and cell pro-
liferation during lung regeneration (Figure 1A and 1B),
with the top two most significant networks focused on cell
cycle (Ccnbl, Cc2, Ccna2, Birc5 and Foxm1), and mesen-
chymal cell proliferation (Igf1, Cyr61, Tnfrsf12a, Ctgf,
Igfbp3 and Ifgbp2) respectively.
Time-dependent transcriptomic patterns during lung 
regeneration
The analysis of differentially expressed transcripts
observed at each of the four individual time points is sum-
marized by the top networks (Figures 2, 3, 4 and 5) as
defined by IPA. As demonstrated in Figure 2, the top net-
works identified by IPA at 6 hours after pneumonectomy
are associated with cell-cell signaling (including up-regu-Respiratory Research 2009, 10:92 http://respiratory-research.com/content/10/1/92
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Illustrations of the top gene networks for the time-independent microarray analysis Figure 1
Illustrations of the top gene networks for the time-independent microarray analysis. A - Most significant network 
for the time-independent microarray analysis (score = 56). B - Second most significant network for the time-independent 
microarray analysis (score = 45).
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Illustrations of the top gene networks at the 6 hour time point of the time-dependent microarray analysis Figure 2
Illustrations of the top gene networks at the 6 hour time point of the time-dependent microarray analysis. A - 
most significant gene network (score = 38). B - second most significant network (score = 36).
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Illustrations of the top gene networks at the 1 day time point of the time-dependent microarray analysis Figure 3
Illustrations of the top gene networks at the 1 day time point of the time-dependent microarray analysis. A - 
most significant gene network (score = 42). B - second most significant network (score = 38).
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Illustrations of the top gene networks at the 3 day time point of the time-dependent microarray analysis Figure 4
Illustrations of the top gene networks at the 3 day time point of the time-dependent microarray analysis. A - 
most significant gene network (score = 57). B - second most significant network (score = 45).
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Illustrations of the top gene networks at the 7 day time point of the time-dependent microarray analysis Figure 5
Illustrations of the top gene networks at the 7 day time point of the time-dependent microarray analysis. A - 
most significant gene network (score = 48). B - second most significant network (score = 42).
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lation of Ceacam1 and ItgaV - Figure 2A), and inhibition
of inflammatory cell migration (down-regulation of the
pro-inflammatory cytokines Cxcl1 and Cxcl10, as well as
Nfκβ - Figure 2B), demonstrating a major shift in regula-
tion of cell adhesion and inflammatory response at this
early time point. The top networks identified by IPA at 1
day (Figure 3) are associated with continued modulation
of the inflammatory response (up-regulation of Egr1, but
down-regulation of Dbp and SerpinB2 - Figure 3A), espe-
cially focused on T-cell development and function (up-
regulation of Cd4, Cd3e, Cd28, Cd247 and Lak - Figure
3B). At 3 days the top networks identified by IPA involve
cell cycle progression (up-regulation of Foxm1, Cdc2,
Cdc20, Ccnd1 and IL6 - Figure 4A), and activation of
fibroblastic cells with production of extracellular matrix
components (up-regulation of Igf1, Tnfrsf12A, Eln, Fbn1,
Col3A1, Serpine1 and Thbs1 - Figure 4B). Finally, at 7
days, the top networks are focused on immunomodula-
tion and inflammatory responses (up-regulation of
NPPA/ANP and Brca1 - Figure 5A), and continued cell
proliferation (up-regulation of Birc5, Foxm1, Cdc2,
Ccnb1 and Ccna2 - Figure 5B).
Proliferation of S100A4 positive parenchymal cells 
following pneumonectomy
Analysis of transcriptomic patterns during post-pneu-
monectomy lung regeneration suggests an integral role for
mesenchymal cells, in particular in the production of
extracellular matrix as mentioned above. To further eluci-
date the role of mesenchymal cells, an immunohisto-
chemical analysis of the regenerating parenchyma was
performed using the fibroblast marker S100A4 (Fsp1)
[22-24]. Mice were fed BrdU in drinking water between
days 1-3 (measured on day 3) or on days 4-7 (measured
on day 7) post-pneumonectomy or sham thoracotomy.
To understand their role in alveologenesis, S100A4+ cells
were enumerated specifically in the alveolar parenchyma
(Figure 6), although proliferating S100A4+ cells were also
seen in the perivascular, peribronchiolar, and pleural
regions. After PNY, there was a significant (P  < 0.05)
Topography of S100A4/BrdU double positive alveolar cells Figure 6
Topography of S100A4/BrdU double positive alveolar 
cells. Photomicrographs (630× magnification) of double pos-
itive staining cells, with S100A4 (green), BrdU (red) and 
nuclei (blue).



Percentage of nucleated cells that stained positive for either  S100A4, BrdU or double positive for S100A4 and BrdU Figure 7
Percentage of nucleated cells that stained positive 
for either S100A4, BrdU or double positive for 
S100A4 and BrdU. Data are mean values ± SE. *P < 0.05 
between PNY and SHAM for a given time point.


Topography of αSMA positive cells 7 days after pneumonec- tomy Figure 8
Topography of αSMA positive cells 7 days after pneu-
monectomy. Photomicrograph (400× magnification) with 
αSMA (green), BrdU (red) and nuclei (blue), illustrating 
αSMA staining around a vessel, but not in surrounding alveoli 
or associated with BrdU positive cells. Similar results were 
seen at 3 days after pneumonectomy and in sham-operated 
animals (results not shown).
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increase in the percentage of total nucleated cells that were
positive for S100A4, BrdU, or S100A4 in combination
with BrdU (Figure 7). Significantly more S100A4+ or
S100A4+/BrdU+ cells were observed after PNY (vs SHAM)
on day 3 but not on day 7, although the percentage of
BrdU+ cells was increased to similar levels by PNY on days
3 and 7. Therefore, it appears that S100A4+ cells prolifer-
ated only in the early period of lung regeneration (day 1-
3). In contrast to S100A4, the myofibroblast marker
αSMA was only detected in the perivascular and peribron-
chial regions, and these cells were not associated with
BrdU uptake (Figure 8).
Discussion
The murine response to pneumonectomy represents a
unique biological phenomenon among adult mammals.
By understanding the molecular signaling that defines
alveolar regeneration in this species, novel targets to pro-
mote lung regeneration in higher mammals may be
revealed. Transcriptomic patterns and cell proliferation
data during post-pneumonectomy lung regeneration sug-
gest that mesenchymal cells appear to be critical for
rebuilding the infrastructure of the lung in this setting.
Their proliferation corresponds to an increase in expres-
sion of extracellular matrix structural genes and proteases
that are essential for tissue remodeling. While it may seem
obvious that mesenchymal cells rebuild the post-pneu-
monectomy lung, the specific pattern of transcription and
associated gene networks have not been systematically
evaluated in this model. Patterns of growth factor expres-
sion suggest that these cells influence the growth and
migration of epithelial and endothelial cells in a paracrine
fashion. Furthermore there is an increase in expression of
"anti-inflammatory" cytokines which may be important
in preventing an over-exuberant innate immune response,
and for prevention of fibrosis. Which of these processes
are specifically carried out by mesenchymal cells warrants
further investigation. However, our initial analysis shows
that S100A4+ fibroblast-like cells, but not αSMA+ myofi-
broblasts, are proliferating cells that contribute to the
transcriptomic pattern observed here.
Mesenchymal cell proliferation and immunomodulation 
during lung regeneration
The transcriptomic patterns suggest that mesenchymal
cells are activated during lung regeneration, resulting in
increased expression of common extracellular matrix
components, in concert with transcriptional control of
inflammatory and immunomodulatory pathways. The
end result of this well orchestrated process is a non-fibro-
genic form of 'wound healing'. The role of fibroblasts and
myofibroblasts in alveolar regeneration was further inves-
tigated using immunohistochemical analysis of two
markers, S100A4 and αSMA that have been previously
associated with fibroblasts and myofibroblasts respec-
tively [22-24]. This analysis confirmed that S100A4-posi-
tive fibroblastic cells proliferate in the lung parenchyma
during lung regeneration (3 days), but are later down-reg-
ulated (7 days). Although S100A4 was not up-regulated at
the transcriptional level during lung regeneration, this is
consistent with regulation via post-transcriptional modu-
lation as seen in other systems [25]. In contrast, αSMA
staining was only associated with vessels and not prolifer-
ating parenchymal cells, suggesting that myofibroblasts
are not highly active in the process of alveolar regenera-
tion. These data suggest that while fibroblast proliferation
is important during lung regeneration, subsequent down-
regulation of fibroblast proliferation and minimization of
myofibroblastic differentiation may be equally important
to avoid parenchymal fibrosis.
Persistent proliferation of S100A4-positive fibroblasts has
been associated with fibrotic diseases such as murine ble-
omycin-induced fibrosis, in which S100A4-positive cell
numbers peak at 2-3 weeks and are still above baseline at
4 weeks [23]. Therefore, it is crucial to better understand
how fibroblast proliferation can participate in lung regen-
eration without myofibroblastic differentiation and/or
subsequent fibrosis. One possibility is that a combination
of reduced Tgfβ signaling activity and reduced pro-inflam-
matory Th-2 cytokine production controls this response.
For example, atrial natriuretic peptide (ANP, encoded by
Nappa) is up-regulated during post-pneumonectomy
lung regeneration, but down-regulated in OVA-induced
asthma, a process associated with a fibrotic response [26].
ANP is anti-fibrotic, and acts through inhibition of Tgfβ-
induced fibroblast transformation [27]. The combined
effects of different growth factors can also modulate the
actions of Tgfβ on cell proliferation and collagen produc-
tion in fibroblast trans-differentiation. For example, Tgfβ
generally induces myofibroblast differentiation, with con-
current increased production of αSMA and type I and III
collagen [28]. However, the presence of either Egf or Igf
can influence fibroblasts to undergo cell proliferation and
DNA synthesis (Igf), or differentiation and αSMA produc-
tion (Egf) [28]. The actions of Igf1 depend largely on its
binding to extracellular proteins such as Igfbp2 and
Igfbp3 [29-31]. While Igf1 and Igfbp2 are up-regulated
during lung regeneration, Igfbp3 is down-regulated.
Increased Igfbp3 expression is associated with emphy-
sema [32] and senescent fibroblasts, where it results in
Igf1 sequestration and reduced cell proliferation [33,34].
Conversely, Igfbp2 binds to extracellular matrix or fibrob-
lasts in the presence of Igf1 or Igf2 and increases their
local bioavailability [35,36]. Since Igf1 signaling is highly
invoked during post-pneumonectomy lung regeneration,
the actions of Igf1 might contribute to a proliferative
rather than fibrotic fibroblast phenotype.Respiratory Research 2009, 10:92 http://respiratory-research.com/content/10/1/92
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Although fibroblast proliferation is a common feature of
lung regeneration and pulmonary fibrotic diseases, the
early (6 hour and 1 day) down-regulation of cytokines
and chemokines involved in inflammatory cell migration
(Figure 2B), and up-regulation of genes involved in T cell
development and function (Figure 3B) is unique to lung
regeneration. Arginase 1 (Arg1) expressed by Th2-induced
fibroproliferative M2 macrophages [37] is also up-regu-
lated during OVA-induced asthma [26], but down-regu-
lated during post-pneumonectomy lung regeneration.
These data suggest an important role for reduced inflam-
matory response, immunomodulation, and M1 rather
than M2 macrophages in successful lung repair/regenera-
tion. These patterns may represent important mechanisms
for balancing cell proliferation and extracellular matrix
remodeling without incurring fibrotic scarring resulting
from the action of exuberant pro-inflammatory cascades.
In contrast to the early anti-inflammatory transcriptomic
pattern observed during lung regeneration in this study,
another recent study describes up-regulation of select
inflammatory cytokines (Hmgb1 and INF-y) during post-
pneumonectomy lung regeneration, although most
cytokines studied were unaffected by the procedure [38].
Does adult alveolar regeneration recapitulate lung 
alveolar development?
Both the observed transcriptomic patterns and the results
of the immunohistochemical analysis suggest that adult
alveolar regeneration is not identical to lung alveolar
development. Myofibroblasts have been previously
described as essential effector cells in post-natal secondary
septation and alveolarization, with characteristic α-SMA
synthesis and localization to developing alveolar septa
[39,40]. In contrast, little αSMA expression is present in
the parenchyma during post-pneumonectomy lung regen-
eration, and immunohistochemical localization of αSMA
suggests that activated myofibroblasts are absent from
alveolar structures. Igf signaling and mRNA expression
patterns are up-regulated during alveolar development
[41,42], a trend which is also apparent in lung regenera-
tion transcriptomic patterns. However, other common
signaling pathways such as Fgf [43-45], Pdgf signaling
[46] and HoxA5 [47] have been implicated in alveolar
development, but are not significantly present in tran-
scriptomic patterns during lung regeneration. These dif-
ferences could represent alterations between the ontogeny
of alveolar development and post-pneumonectomy lung
regeneration, or may reflect the broad experimental
design of our study, which may have reduced our ability
to detect subtle and/or temporally restricted changes.
Conclusion
Analysis of transcriptomic patterns at four time points
during post-pneumonectomy lung regeneration reveals
significant insight into the regeneration of normal lung
tissue after partial pneumonectomy. By including both
time-independent and time-dependent analyzes, the data
provides insight into important checks and balances that
are activated to facilitate growth of functional lung tissue
without fibrogenesis. Analysis of the data set using IPA
revealed two themes that are important in the process of
lung regeneration. The first is the transcriptomic patterns
consistent with activation of mesenchymal cells, and the
second is transcriptomic patterns consistent with anti-
inflammatory immunomodulatory activity. The presence
of proliferating mesenchymal cells in the alveolar paren-
chyma was also demonstrated immunohistochemically.
Although proliferating S100A4+ cells (fibroblasts) have
been previously associated with fibrotic scarring, this data
demonstrates that S100A4+ cells can actively participate
in non-fibrogenic tissue regeneration in the lung [48]. In
lung regeneration, it may be the influence of immune
modulation and modulation of the inflammatory
response that is responsible for balancing cell prolifera-
tion and extracellular re-modeling against fibrosis.
Taken together with previous reports examining the
mechanism of lung regeneration, we can speculate that
from the initial stimulus of increased mechanical stress
and hypoxia [2], post-pneumonectomy lung regeneration
occurs through a combination of early immediate gene
expression [9,10], up-regulation of genes important in cell
cycle regulation and cell proliferation, and the careful
orchestration of fibroblast proliferation, extracellular
matrix deposition and immunomodulation to prevent
excessive fibrosis. Our study provides a unique descrip-
tion of transcriptomic patterns and mesenchymal cell pro-
liferation during post-pneumonectomy lung regeneration
in the adult mouse. However, better understanding of bio-
logically important mechanisms using transgenic models,
lineage tagging, and transplant models will be important
to further understand the process of lung regeneration.
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